Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by CancerVAX, Inc
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
December 17, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
October 14, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
September 03, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Achieves Major Milestones and Files Foundational Patent Application
August 26, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Scientists Discuss the Recent CancerVax Breakthrough
August 19, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
August 05, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
June 19, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
June 09, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle
June 05, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
June 03, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
February 27, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Successful Tests of its Smart mRNA Technology
February 25, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Passes First Test with Flying Colors
December 20, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Lands Top Cancer Expert
November 19, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
August 27, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Adds Key Members to Its Research Team
August 01, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
May 21, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
April 16, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Launches $5 Million Funding Round
April 03, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer Treatments
September 14, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Expands Development Pipeline to Include a Universal CAR-T Cell Platform
September 12, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses Cancer Drug Development with Dr. Ezra Cohen
November 02, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Physician-Scientist
August 24, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
World Renowned Biomedical Professor Jonathan Lakey Joins CancerVAX Board of Advisors
July 26, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan
July 10, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA
June 27, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Biotech Executive Michael Smith Discusses the FDA Drug Development Process with CancerVAX CEO Ryan Davies
June 16, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Launches $10 Million Funding Round
June 14, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today